Visioneering Technologies (ASX:VTI) EV-to-EBIT : -0.52 (As of May. 16, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Visioneering Technologies's Enterprise Value is A$2.63 Mil. Visioneering Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-5.02 Mil. Therefore, Visioneering Technologies's EV-to-EBIT for today is -0.52.

The historical rank and industry rank for Visioneering Technologies's EV-to-EBIT or its related term are showing as below:

ASX:VTI' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.6 Med: -0.4 Max: 2.53
Current: -0.53

During the past 7 years, the highest EV-to-EBIT of Visioneering Technologies was 2.53. The lowest was -3.60. And the median was -0.40.

ASX:VTI's EV-to-EBIT is ranked worse than
100% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.415 vs ASX:VTI: -0.53

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Visioneering Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was A$8.34 Mil. Visioneering Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-5.02 Mil. Visioneering Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -60.16%.

Visioneering Technologies EV-to-EBIT Historical Data

The historical data trend for Visioneering Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies EV-to-EBIT Chart

Visioneering Technologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-1.22

-2.26

-3.26

-0.85

-1.66

Visioneering Technologies Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial									-3.26	-	-0.85	-	-1.66

Competitive Comparison of Visioneering Technologies's EV-to-EBIT

For the Medical Devices subindustry, Visioneering Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Visioneering Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's EV-to-EBIT falls into.

Visioneering Technologies EV-to-EBIT Calculation

Visioneering Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	2.629	/	-5.019
	=	-0.52

Visioneering Technologies's current Enterprise Value is A$2.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Visioneering Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-5.02 Mil.

Visioneering Technologies (ASX:VTI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Visioneering Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-5.019	/	8.342475
	=	-60.16 %

Visioneering Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was A$8.34 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Visioneering Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-5.02 Mil.

Visioneering Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Visioneering Technologies (ASX:VTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009

Website

http://www.vtivision.com

Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.